Abstract
49P A phase II randomized trial with adjuvant autologous tumor lysate-pulsed dendritic cells (DC) in resected stage III-IV melanoma patients: Preliminary immunological results
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have